| Parameter |
α-tocoferol, μmol/L |
P- value |
Retinol, μmol/L |
P- value |
| |
<12 μmol/L (n=36) (1) |
12-42 μmol/L (n=17) (2) |
|
<1.05 μmol/L (n=35) (3) |
1.05-2.8 μmol/L (n=18) (4) |
|
| Menstrual cycle disorders |
63.9%(23) |
35.3%(6) |
0.045* |
48.6%(17) |
66.7%(12) |
0.254 |
| Amenorrhea |
19.4%(7) |
5.9%(1) |
0.412 |
11.4%(4) |
22.2%(4) |
0.421 |
| Oligomenorrhea |
36.1%(13) |
29.4%(5) |
0.760 |
34.3%(12) |
33.3%(6) |
1.000 |
| Opsomenorrhea |
19.4%(7) |
23.5%(4) |
0.730 |
14.3%(5) |
33.3%(6) |
0.154 |
| The presence of total infertility |
36.1%(14) |
11.8%(2) |
0.048* |
28.6%(10) |
27.8%(5) |
1.000 |
| Primary |
22.2%(8) |
(0) |
0.044* |
17.1%(6) |
5.6%(1) |
0.401 |
| Secondary |
17.1%(6) |
11.8%(2) |
1.000 |
11.4%(4) |
22.2%(4) |
0.421 |
| Structure of the causes of infertility |
| Tubal-peritoneal Factor |
2.8%(1) |
(0) |
1.000 |
25.7%(9) |
22.2%(4) |
1.000 |
| Endocrine infertility |
30.6%(11) |
11.8%(2) |
0.163 |
25.7%(9) |
22.2%(4) |
1.000 |
| Uterine factor |
13.9%(5) |
(0) |
0.159 |
11.4%(4) |
5.6%(1) |
0.651 |
| Luteal phase deficiency |
61.1%(22) |
47.1%(8) |
0.001* |
54.3%(19) |
61.1%(11) |
0.772 |
| Decreased ovarial reserve |
11.1%(4) |
11.8%(2) |
1.000 |
11.4%(4) |
11.1%(2) |
1.000 |
|
